Ocular Therapeutix
OCUL
OCUL
113 hedge funds and large institutions have $127M invested in Ocular Therapeutix in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
16% less funds holding
Funds holding: 135 → 113 (-22)
43% less capital invested
Capital invested by funds: $224M → $127M (-$97.2M)
73% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 30
Holders
113
Holding in Top 10
2
Calls
$1.04M
Puts
$350K
Top Buyers
| 1 | +$2.16M | |
| 2 | +$828K | |
| 3 | +$646K | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$523K |
| 5 |
Axa
Paris,
France
|
+$516K |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$3.33M | |
| 3 | -$1.55M | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$1.35M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$1.14M |